跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Kanjinti - SFDA Drug Approval Details
Approvals
/
SFDA
/
Kanjinti
Authorized
BIOLOGICAL
Kanjinti
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
dc3d3628af623b69
Company
Unknown
Type
Biological
Approval Details
Approval Id
dc3d3628af623b69
Drug Approval Sfda Name
Kanjinti
Trade Name
Kanjinti
Generic Name
Trastuzumab
Register Number
2211200282
Register Year
2020
Drug Type
Biological
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store in a refrigerator (2°c – 8°c)
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000001268-150-100000074029
Price
1364.7
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
dc3d3628af623b69
Type
Biological
Back to SFDA Approvals